Getting your player ready...
SHANGHAI — Medical-research equipment and services company Charles River Laboratories International plans to buy WuXi PharmaTech, a Chinese pharmaceutical outsourcing company, for $1.6 billion.
Foreign drug companies have been rushing to expand research-and-development operations in fast-growing China, with much of the activity concentrated in the Shanghai region, where WuXi Pharma- Tech is located.
